Marshall Wace
ACH

Marshall Wace’s Accendra Health ACH Stock Holding History

Marshall Wace’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.83M Buy
2,582,579
+821,575
+47% +$2.55M 0.01% 1089
2026
Q1 		$4.02M Buy
1,761,004
+1,226,988
+230% +$2.83M ﹤0.01% 1406
2025
Q4 		$1.5M Buy
+534,016
New +$1.91M ﹤0.01% 1729
2025
Q1 		– Sell
-73,692
Closed -$963K – 2964
2024
Q4 		$963K Buy
73,692
+56,192
+321% +$749K ﹤0.01% 1752
2024
Q3 		$275K Buy
17,500
+6,400
+58% +$97K ﹤0.01% 2186
2024
Q2 		$150K Buy
11,100
+3,077
+38% +$63K ﹤0.01% 2347
2024
Q1 		$222K Sell
8,023
-179,882
-96% -$3.99M ﹤0.01% 2203
2023
Q4 		$3.62M Sell
187,905
-327,447
-64% -$5.93M 0.01% 1024
2023
Q3 		$8.33M Buy
515,352
+247,743
+93% +$4.4M 0.02% 704
2023
Q2 		$5.1M Buy
267,609
+200,634
+300% +$3.58M 0.01% 1010
2023
Q1 		$974K Buy
+66,975
New +$1.2M ﹤0.01% 1828
2022
Q4 		– Sell
-143,607
Closed -$3.46M – 3288
2022
Q3 		$3.46M Buy
+143,607
New +$4.43M 0.01% 1653
2021
Q2 		– Sell
-23,467
Closed -$881K – 2959
2021
Q1 		$881K Sell
23,467
-5,635
-19% -$176K ﹤0.01% 1727
2020
Q4 		$787K Buy
+29,102
New +$749K ﹤0.01% 1311
2020
Q1 		– Sell
-14,151
Closed -$73K – 1943
2019
Q4 		$73K Sell
14,151
-215,261
-94% -$1.38M ﹤0.01% 1504
2019
Q3 		$1.33M Buy
229,412
+182,869
+393% +$820K 0.01% 869
2019
Q2 		$149K Buy
+46,543
New +$159K ﹤0.01% 1260
2017
Q1 		– Sell
-89,427
Closed -$3.16M – 620
2016
Q4 		$3.16M Buy
+89,427
New +$3.02M 0.02% 562
2014
Q3 		– Sell
-7,500
Closed -$255K – 990
2014
Q2 		$255K Buy
+7,500
New +$257K ﹤0.01% 793

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.84B AUM 38.84% 1-Year Est. Return

Marshall Wace's ACH Position: Q2 2026 in Review

Marshall Wace increased its Accendra Health (ACH) stake by 47% in Q2 2026, buying an estimated $2.55M and bringing the position to 2,582,579 shares worth $8.83M. The position accounts for 0.01% of the portfolio, ranked #1089.

Marshall Wace first reported a position in ACH in Q2 2014 and has held it in 19 quarters since. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Marshall Wace held 2,582,579 shares of Accendra Health worth $8.83M as of Q2 2026.
  • Marshall Wace bought 821,575 Accendra Health shares in Q2 2026, an estimated $2.55M.
  • Accendra Health made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1089 holding.
  • Marshall Wace first reported a position in Accendra Health in Q2 2014 and has held it in 19 quarters since.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.